Skip to main content
All lobbying filings

PHILIPS HOLDING USA, INC.

Lobbying for PHILIPS HOLDING USA INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $640,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 9
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
  • HR 1219
    Oral Health Products Inclusion Act
  • S 1399
    Health Tech Investment Act
  • HR 6197
    Health Tech Investment Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 4519
    Medical Device Electronic Labeling Act
  • HR 1539
    Medical Device Electronic Labeling Act
 Lobbying activity 7
Budget/Appropriations

FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

Veterans

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Defense

S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD

Tariff (miscellaneous tariff bills)

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Taxation/Internal Revenue Code

H.R. 1219, Oral Health Products Inclusion Act (whole bill)

Medicare/Medicaid

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)

Health Issues

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem